1. Home
  2. MCBS vs MLTX Comparison

MCBS vs MLTX Comparison

Compare MCBS & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MetroCity Bankshares Inc.

MCBS

MetroCity Bankshares Inc.

HOLD

Current Price

$34.58

Market Cap

992.1M

Sector

Finance

ML Signal

HOLD

Logo MoonLake Immunotherapeutics

MLTX

MoonLake Immunotherapeutics

HOLD

Current Price

$10.59

Market Cap

863.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCBS
MLTX
Founded
2006
2021
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
992.1M
863.0M
IPO Year
2019
2020

Fundamental Metrics

Financial Performance
Metric
MCBS
MLTX
Price
$34.58
$10.59
Analyst Decision
Buy
Analyst Count
0
15
Target Price
N/A
★ $28.54
AVG Volume (30 Days)
85.8K
★ 1.7M
Earning Date
11-03-2026
11-04-2026
Dividend Yield
★ 3.33%
N/A
EPS Growth
★ 4.76
N/A
EPS
★ 1.53
N/A
Revenue
N/A
N/A
Revenue This Year
$30.11
N/A
Revenue Next Year
$2.12
N/A
P/E Ratio
$22.78
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$24.53
$9.31
52 Week High
$37.46
$23.29

Technical Indicators

Market Signals
Indicator
MCBS
MLTX
Relative Strength Index (RSI) 46.47 40.60
Support Level $33.57 $10.00
Resistance Level $35.60 $19.32
Average True Range (ATR) 0.68 0.58
MACD 0.02 0.09
Stochastic Oscillator 28.44 50.43

Price Performance

Historical Comparison
MCBS
MLTX

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a bank holding company. Through its banking subsidiary, it operates as a full-service commercial bank focused on delivering various financial products and services to the small-to medium-sized businesses and individuals in its markets, including many customers in diverse and multi-ethnic communities in metropolitan markets in the Eastern U.S., Texas and California. The company provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers, and a variety of other banking services. The majority of its revenue is generated in the form of interest income.

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.

Share on Social Networks: